Philips launches AI-enhanced cardiovascular ultrasound platform, improving cardiac imaging, efficiency, and patient care decisions.

Philips launches AI-enabled cardiovascular ultrasound platform, integrating FDA-cleared AI applications into its EPIQ CVx and Affiniti CVx ultrasound systems. The platform speeds up cardiac ultrasound analysis, automates measurements, and enhances workflows, increasing productivity. Trained on real-life clinical data sets, the AI features aim to improve the quality and reproducibility of cardiac imaging, enhance operator and departmental efficiency, and support better-informed decisions for patients with heart valve disease.

June 03, 2024
10 Articles